# Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

> **NCT02317562** · PHASE3 · TERMINATED · sponsor: **Laboratoire français de Fractionnement et de Biotechnologies** · enrollment: 19 (actual)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyradiculoneuropathy

## Interventions

- **DRUG:** I10E

## Key facts

- **NCT ID:** NCT02317562
- **Lead sponsor:** Laboratoire français de Fractionnement et de Biotechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-07-28
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317562, "Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02317562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*